Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Los Angeles Facial Aesthetic Specialist Dr. Alexander Rivkin Leads the Way in Botox Treatment for Platysmal Bands


News provided by

RIVKIN Aesthetics

Dec 03, 2024, 13:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Alexander Rivkin
Dr. Alexander Rivkin

Dr. Alexander Rivkin, a renowned non-surgical aesthetic specialist, played a pivotal role as a principal investigator in the FDA approval study of Botox® for platysmal bands. With over 15 years of expertise in treating neck bands using botulinum toxins, Dr. Rivkin continues to lead advancements in non-surgical neck rejuvenation techniques.

LOS ANGELES, Dec. 3, 2024 /PRNewswire-PRWeb/ -- Dr. Alexander Rivkin, a world-renowned expert in non-surgical aesthetic medicine, continues to set benchmarks in the field of cosmetic enhancements. As one of the principal investigators in the pivotal clinical study that led to FDA approval of Botox® for treating platysmal bands, Dr. Rivkin has been at the forefront of this groundbreaking aesthetic innovation. With over 15 years of experience successfully treating neck bands with botulinum toxins, including Botox® and other brands, Dr. Rivkin's expertise solidifies his reputation as a leader in aesthetic medicine.

FDA Approval Marks a Milestone for Non-Surgical Neck Rejuvenation
The recent FDA approval of Botox® Cosmetic (onabotulinumtoxinA) for the treatment of moderate to severe platysmal bands offers patients a minimally invasive solution for smoother neck contours. Platysmal bands, the vertical lines that connect the jawline to the neck, are often associated with aging or muscle activity, and their prominence can detract from an otherwise youthful appearance.

"It's an honor to have been part of the clinical research that expanded Botox®'s FDA-approved applications and to help shape the future of aesthetic medicine," said Dr. Rivkin.

Post this

Botox® Cosmetic is now the only product FDA-approved for four aesthetic indications: frown lines, forehead lines, crow's feet, and platysmal bands. This advancement enhances the portfolio of aesthetic solutions for patients seeking comprehensive facial and neck rejuvenation without surgery.

Dr. Alexander Rivkin's Pioneering Role
Dr. Rivkin's role as a principal investigator in the Botox® for platysmal bands study highlights his commitment to advancing the field of non-surgical aesthetics. For over 15 years, Dr. Rivkin has successfully used botulinum toxins to treat platysmal bands, tailoring his approach to deliver natural and harmonious results for his patients.

"Neck bands can be a significant concern for patients who want a rejuvenated appearance but aren't ready for surgery. Botox® offers a simple, effective, and minimally invasive option that has transformed the way we approach neck rejuvenation," said Dr. Rivkin. "It's an honor to have been part of the clinical research that expanded Botox®'s FDA-approved applications and to help shape the future of aesthetic medicine."

Enhancing Patient Outcomes Through Expertise
Dr. Rivkin's deep understanding of facial and neck anatomy, combined with his advanced injection techniques, ensures optimal outcomes for his patients. His extensive experience allows him to provide individualized care that balances artistry and precision, enhancing natural beauty while prioritizing safety and efficacy.

With the FDA approval of Botox® for platysmal bands, patients now have a trusted option for addressing this common aesthetic concern. Dr. Rivkin remains dedicated to educating both patients and providers about the benefits of this treatment and its potential to redefine non-surgical rejuvenation.

More About Dr. Alexander Rivkin
Dr. Alexander Rivkin, MD, is a Yale-trained facial cosmetic specialist and the founder of Westside Aesthetics in Los Angeles. Known as a pioneer in non-surgical cosmetic procedures, Dr. Rivkin introduced the concept of non-surgical rhinoplasty, a treatment that has become his signature procedure. He is also highly sought after for his expertise in injectable treatments, including Botox®, dermal fillers, and other advanced non-surgical techniques.

Dr. Rivkin is deeply committed to advancing the field of aesthetic medicine through research, education, and clinical excellence. He frequently lectures at international conferences and has authored numerous articles on innovative techniques in aesthetic medicine.

For more information about Dr. Alexander Rivkin and his treatments, please visit http://www.westsideaesthetics.com or call 310-443-5273.

Media Contact

Sarah Oleszak, RIVKIN Aesthetics, 310-443-5273, Sarah@westsideaesthetics.com, https://westsideaesthetics.com/

SOURCE RIVKIN Aesthetics

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.